​

Funding Round

Post-IPO Equity - Krystal Biotech

Post-IPO Equity - Krystal Biotech

Investment Firm

Overview

Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..

Announced Date

May 21, 2023

Funding Type

Post Ipo Equity

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Avoro Capital Advisors

Avoro Capital Advisors

Avoro Capital Advisors is a post_ipo and private_equity firm.

Redmile Group

Redmile Group

Redmile Group is a early_stage_venture and late_stage_venture and post_ipo and private_equity firm.

Participant Investors

4

Investor Name
Participant InvestorFrazier Life Sciences
Participant InvestorBraidwell
Participant InvestorRedmile Group
Participant InvestorAvoro Capital Advisors

Round Details and Background

Krystal Biotech raised $160000000 on 2023-05-21 in Post-IPO Equity

Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 17, 2018
Post-IPO Equity - Krystal Biotech
-69.0M
Nov 29, 2021
Post-IPO Equity - Krystal Biotech
-200.0M
May 21, 2023
Post-IPO Equity - Krystal Biotech
4-160.0M
Aug 08, 2017
Funding Round - Krystal Biotech
1-7.0M

Recent Activity

There is no recent news or activity for this profile.